Fund Holdings — Versant Venture Management, LLC

Total Portfolio Value:
$212.45M
Total Bought:
$123.76M
Total Sold:
$14.60M
Net Transaction:
+$109.15M
Notable People:
Brian G. Atwood, Samuel D. Colella, Bradley J. Bolzon, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, Kirk G. Nielsen, Robin L. Praeger, Charles M. Warden, Brian G. Atwood, Bradley J. Bolzon, Samuel D. Colella, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, Charles M. Warden, Brian G. Atwood, Bradley J. Bolzon, Samuel D. Colella, Ross A. Jaffe, William J. Link, Barbara N. Lubash, Donald B. Milder, Robin L. Praeger, Charles M. Warden, Brian G. Atwood, Bradley J. Bolzon, Samuel D. Colella, Ross A. Jaffe, William J. Link, Kirk G. Nielsen, Robin L. Praeger, Charles M. Warden, Robin L. Praeger, Robin L. Praeger, Thomas F. Woiwode, Samuel D. Colella, William J. Link, Kirk G. Nielsen, Bradley J. Bolzon, Thomas F. Woiwode, Thomas F. Woiwode, Bradley J. Bolzon, Robin L. Praeger, Kirk G. Nielsen, Thomas F. Woiwode, Versant Ventures Vi Gp-, Versant Venture, Versant Ventures Vii Gp-, Versant Vantage I Gp-Gp,, Bradley J. Bolzon, Jerel Clayton Davis, Robin L. Praeger, Thomas F. Woiwode, Clare Ozawa, Clare Ozawa, Thomas F. Woiwode, Robin L. Praeger, Jerel Clayton Davis, Bradley J. Bolzon, Versant Ventures Vi Gp,, Jerel Clayton Davis, Jerel Clayton Davis, Clare Ozawa, Jerel Clayton Davis, Clare Ozawa, Alexander Volker Mayweg, Alexander Volker Mayweg, Versant Vantage Ii Gp-Gp,, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Robin L. Praeger, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Ventures Viii Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Robin L. Praeger, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Ventures Viii Gp-, Versant Voyageurs Ii Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Robin L. Praeger, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Voyageurs Ii Gp-, Versant Vantage Iii Gp-Gp,, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Ventures Ix Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Voyageurs Iii Gp-, Bradley J. Bolzon, Jerel Clayton Davis, Clare Ozawa, Thomas F. Woiwode, Alexander Volker Mayweg, Versant Vantage Iii Gp-Gp,, Versant Ventures Ix Gp-, Versant Voyageurs Iii Gp-, Carlo Dante Rizzuto, Carlo Dante Rizzuto, Carlo Dante Rizzuto, Carlo Dante Rizzuto
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
LENZ Therapeutics, Inc.(LENZ)02,656,888+2,656,888$0$123.76M58.25%+$123.76M
Monte Rosa Therapeutics, Inc.(GLUE)5,652,9225,652,9220$25.49M$41.89M19.72%+$16.39M
Jade Biosciences, Inc.1,525,8201,525,8200$15.24M$13.17M6.20%-$2.08M
CRISPR Therapeutics AG(CRSP)498,558148,831-349,727$24.25M$9.65M4.54%-$14.60M
Skye Bioscience, Inc.(SKYE)2,007,7042,007,7040$8.39M$7.89M3.71%-$501.9K
Contineum Therapeutics, Inc.(CTNM)542,628542,6280$2.15M$6.38M3.00%+$4.22M
Repare Therapeutics, Inc.2,646,6572,646,6570$3.68M$4.66M2.19%+$979.3K
Tempest Therapeutics, Inc.(TPST)269,772269,7720$1.83M$2.77M1.31%+$938.8K
Adverum Biotechnologies, Inc.506,821506,8210$1.09M$2.30M1.08%+$1.21M
Page 1 of 1